Table 1.
Participant | Age | Gender | Site of Onset |
Disease Duration (years) |
ALSFRS-R (/48) |
MMSE (/30) |
ALS-CBS (/21) |
Ed |
---|---|---|---|---|---|---|---|---|
1 | 64 | Female | Spinal | 1.57 | 13 | N/A | N/A | B |
2 | 60 | Male | N/A | N/A | N/A | 30 | N/A | M.S. |
3 | 60 | Male | Bulbar | 1.21 | 37 | 30 | 17 | B |
4 | 65 | Female | Bulbar | 3.67 | 22 | 27 | 10 | N/A |
5 | 64 | Male | Spinal | 4.19 | 21 | 23 | 16 | M.S. |
6 | 69 | Male | Spinal | 2.67 | 25 | 24 | 8 | Ph.D. |
7 | 57 | Female | N/A | N/A | N/A | 25 | N/A | GED |
8 | 68 | Female | Bulbar | 2.25 | 39 | 30 | 20 | HS |
9 | 60 | Male | Spinal | 1.94 | 36 | 30 | N/A | HS |
Avg | 63.0 ± 4.0 | 56% Male | N/A | 2.50 ± 1.09 | 28 ± 9.8 | 27.4 ± 3.0 | 14.2 ± 5.0 | |
Control cohort demographics (n= 18) | ||||||||
63.5 ± 5.3 | 50% Male | N/A | N/A | N/A | 29.9 ± 0.4 | N/A | N/A |